Ferrokin brings in $8.4M for anemia treatment

Ferrokin Biosciences, a San Carlos Calif. company that makes compounds to treat iron overload in patients with anemia, received $8.4 million of what it hopes will be a $15 million first-round of funding from Clarus Ventures, Burrill & Co. and Celegene Inc.

Iron overload is a common side effect of repeated transfusions used to treat certain types of anemia. The company doesn’t have a website, and very little information on it is available.

Next Story: Twitter reports huge usage, no Fail Whales for Election Day
Previous Story: Web 2.0 Summit: Mary Meeker on how long the recession will last